Nishinomiya, Japan

Hirohito Katayama

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990-1994.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 175(Granted Patents)


Location History:

  • Hyogo, JP (1993)
  • Nishinomiya, JP (1990 - 1994)

Company Filing History:


Years Active: 1990-1994

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Hirohito Katayama: Innovator in Pharmaceutical Research

Introduction

Hirohito Katayama is a prominent inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on innovative treatments that leverage chemical compounds for medical applications.

Latest Patents

Among his latest patents is a groundbreaking method for the treatment of pancreatitis. This method involves administering an effective amount of a pyrazolopyridine compound, which has shown promise in medical research. Another notable patent concerns pharmaceutically useful pyrazolopyridines, which are compounds that could lead to new therapeutic options.

Career Highlights

Hirohito Katayama has built a successful career at Fujisawa Pharmaceutical Company, Ltd. His expertise in pharmaceutical chemistry has positioned him as a key figure in the development of new medications. His innovative approaches have contributed to advancements in treatment methodologies.

Collaborations

Throughout his career, Katayama has collaborated with notable colleagues, including Youichi Shiokawa and Takafumi Mitsunaga. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hirohito Katayama's contributions to pharmaceutical research and his innovative patents underscore his importance in the field. His work continues to influence the development of new treatments, showcasing the impact of dedicated inventors in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…